Search

Search Constraints

You searched for: Author/Creator Jourdan, Eric

Search Results

2. Characteristics and clinical outcomes of SARS-CoV-2 infection in adult patients with acute leukemia in France. (September 2022)

3. Conventional chemotherapy for acute myeloid leukemia in older adults: Impact on nutritional, cognitive, and functional status. (27th March 2021)

5. Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Patient-reported Outcomes from the Phase II JAKARTA2 Trial. Issue 5 (29th May 2021)

6. Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure. Issue 6 (17th April 2020)

7. Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study. Issue 7 (July 2017)

8. Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1‐RUNX1T1 fusion quantification on genomic DNA. Issue 6 (8th March 2014)

9. Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate‐risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006‐intermediate‐risk trial. (18th April 2021)

10. Relapsed chronic lymphocytic leukemia retreated with rituximab: interim results of the PERLE study. Issue 6 (3rd June 2017)